149 related articles for article (PubMed ID: 26176889)
1. The effect of volatility on percutaneous absorption.
Rouse NC; Maibach HI
J Dermatolog Treat; 2016; 27(1):5-10. PubMed ID: 26176889
[TBL] [Abstract][Full Text] [Related]
2. The transient dermal exposure II: post-exposure absorption and evaporation of volatile compounds.
Frasch HF; Bunge AL
J Pharm Sci; 2015 Apr; 104(4):1499-507. PubMed ID: 25611182
[TBL] [Abstract][Full Text] [Related]
3. Evaporation of decamethylcyclopentasiloxane (D5) from selected cosmetic products: Implications for consumer exposure modeling.
Dudzina T; Garcia Hidalgo E; von Goetz N; Bogdal C; Hungerbuehler K
Environ Int; 2015 Nov; 84():55-63. PubMed ID: 26222996
[TBL] [Abstract][Full Text] [Related]
4. Use of a Simple in vitro Test to Assess Loss of Chemical due to Volatility during an in vitro Human Skin Absorption Study.
Grégoire S; Cubberley R; Duplan H; Eilstein J; Hewitt NJ; Jacques-Jamin C; Genies C; Klaric M; Rothe H; Ellison C; Fernandez J; Schepky A
Skin Pharmacol Physiol; 2019; 32(3):117-124. PubMed ID: 30889606
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo percutaneous absorption of catechol.
Jung CT; Wickett RR; Desai PB; Bronaugh RL
Food Chem Toxicol; 2003 Jun; 41(6):885-95. PubMed ID: 12738194
[TBL] [Abstract][Full Text] [Related]
6. Do partition coefficients (liphophilicity/hydrophilicity) predict effects of occlusion on percutaneous penetration in vitro: a retrospective review.
Hafeez F; Maibach H
Cutan Ocul Toxicol; 2013 Oct; 32(4):299-303. PubMed ID: 23535019
[TBL] [Abstract][Full Text] [Related]
7. Twenty Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans.
Law RM; Ngo MA; Maibach HI
Am J Clin Dermatol; 2020 Feb; 21(1):85-95. PubMed ID: 31677110
[TBL] [Abstract][Full Text] [Related]
8. Multi-pathway exposure modeling of chemicals in cosmetics with application to shampoo.
Ernstoff AS; Fantke P; Csiszar SA; Henderson AD; Chung S; Jolliet O
Environ Int; 2016; 92-93():87-96. PubMed ID: 27062422
[TBL] [Abstract][Full Text] [Related]
9. Volatility of fragrance chemicals: patch testing implications.
Gilpin SJ; Hui X; Maibach HI
Dermatitis; 2009; 20(4):200-7. PubMed ID: 19804696
[TBL] [Abstract][Full Text] [Related]
10. In vitro percutaneous absorption of benzene in human skin.
Hui X; Wester RC; Barbadillo S; Cashmore A; Maibach HI
Cutan Ocul Toxicol; 2009; 28(2):65-70. PubMed ID: 19514929
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardized protocol.
Hewitt NJ; Grégoire S; Cubberley R; Duplan H; Eilstein J; Ellison C; Lester C; Fabian E; Fernandez J; Géniès C; Jacques-Jamin C; Klaric M; Rothe H; Sorrell I; Lange D; Schepky A
J Appl Toxicol; 2020 Mar; 40(3):403-415. PubMed ID: 31867769
[TBL] [Abstract][Full Text] [Related]
12. Shaving effects on percutaneous penetration: clinical implications.
Hamza M; Tohid H; Maibach H
Cutan Ocul Toxicol; 2015; 34(4):335-43. PubMed ID: 25363065
[TBL] [Abstract][Full Text] [Related]
13. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
Förster M; Bolzinger MA; Fessi H; Briançon S
Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous absorption of an insect repellent p-menthane-3,8-DIOL: a model for human dermal absorption.
Reifenrath WG; Olson JJ; Vedula U; Osimitz TG
J Toxicol Environ Health A; 2009; 72(13):796-806. PubMed ID: 19557607
[TBL] [Abstract][Full Text] [Related]
15. Understanding percutaneous absorption for occupational health and safety.
Wester RC; Maibach HI
Int J Occup Environ Health; 2000; 6(2):86-92. PubMed ID: 10828135
[TBL] [Abstract][Full Text] [Related]
16. Topical and transdermal delivery of caffeine.
Luo L; Lane ME
Int J Pharm; 2015 Jul; 490(1-2):155-64. PubMed ID: 26004004
[TBL] [Abstract][Full Text] [Related]
17. Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces: surface pH values, volatility, and in vitro human skin.
Salocks CB; Hui X; Lamel S; Qiao P; Sanborn JR; Maibach HI
Food Chem Toxicol; 2012 Dec; 50(12):4436-40. PubMed ID: 22902806
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of vapors in human skin.
Rehal B; Maibach H
Cutan Ocul Toxicol; 2011 Jun; 30(2):87-91. PubMed ID: 21091036
[TBL] [Abstract][Full Text] [Related]
19. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin.
Qiao GL; Brooks JD; Baynes RE; Monteiro-Riviere NA; Williams PL; Riviere JE
Toxicol Appl Pharmacol; 1996 Dec; 141(2):473-86. PubMed ID: 8975772
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
Jakasa I; Kezic S
Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
